Department of Oncology, University of Turin, A.O.U. Città della Salute e della Scienza di Torino, Ospedale Molinette, Turin, Italy.
Medical Oncology, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy.
Breast. 2024 Dec;78:103817. doi: 10.1016/j.breast.2024.103817. Epub 2024 Sep 28.
Inclusion of patient-reported outcomes (PROs) in oncology clinical trials is strongly recommended. However, selecting the most appropriate patient-reported outcome measures (PROMs) is not easy. This study aimed to develop a breast cancer (BC) specific comprehensive archive of PROMs.
As part of the PRO4All project, we identified available PROMs in oncology by searching facit.org, eortc.org, eprovide.mapi-trust.org, PubMed, ema.europa.eu (European Public Assessment Reports) and published reviews. For this analysis, only BC tools were extracted. We described information about PROM name, type of questionnaire, questionnaire variant(s), recall period, number of items, and presence of minimum clinically important difference (MCID) reference in literature. Then, we assigned each item to a specific domain according to a predefined taxonomy of 38 items for outcome classification.
We identified and analyzed 383 PROMs. Of these, 29 were BC specific, but 2 were excluded because the questionnaires description was not available. 6 (22.2 %) were variants of another questionnaire. All questionnaires were self-reported. In 6 cases (22.2 %) the recall period to consider was the "last week". The mean number of items per questionnaire was 25.81 (range 6-71). 602 items were assigned to an outcome domain: emotional functioning/wellbeing in 26.6 % of cases, physical functioning in 14.1 %, delivery of care in 10.8 %, and general outcomes in 10.5 %. MCID reference was found only in 4 (14.8 %) cases.
The newly developed archive represents a useful tool to optimize the use of PROMs in the evaluation of treatments in BC patients, promoting a patient-centered approach both in clinical research and practice.
强烈建议将患者报告结局(PROs)纳入肿瘤临床试验。然而,选择最合适的患者报告结局测量工具(PROMs)并不容易。本研究旨在开发一个乳腺癌(BC)专用的全面 PROM 档案。
作为 PRO4All 项目的一部分,我们通过搜索 facit.org、eortc.org、eprovide.mapi-trust.org、PubMed、ema.europa.eu(欧洲公共评估报告)和已发表的综述,确定了肿瘤学中可用的 PROMs。在本分析中,仅提取了 BC 工具。我们描述了 PROM 名称、问卷类型、问卷变体、回忆期、项目数量以及文献中是否存在最小临床重要差异(MCID)参考的信息。然后,我们根据 38 项的预定义分类法将每个项目分配到特定的领域。
我们共识别并分析了 383 个 PROMs。其中,29 个是 BC 专用的,但有 2 个因问卷描述不可用而被排除。6 个(22.2%)是另一个问卷的变体。所有问卷均为自我报告。在 6 个案例中(22.2%),考虑的回忆期为“上周”。每个问卷的平均项目数为 25.81(范围为 6-71)。602 个项目被分配到一个结局领域:情感功能/幸福感占 26.6%,身体功能占 14.1%,护理提供占 10.8%,一般结局占 10.5%。仅在 4 个案例中(14.8%)发现了 MCID 参考。
新开发的档案是优化 BC 患者治疗评估中 PROMs 使用的有用工具,在临床研究和实践中均促进了以患者为中心的方法。